Weekly Psychedelic Links - November 2022

11.4.22

Cannabis

• Legal cannabis is America’s 6th biggest cash crop (Leafly)

• Nevada Judge Orders Cannabis Removed From State’s List of Controlled Substances (High Times)

• Delaware’s Democratic Governor Vetoes Bipartisan Bill To Protect Medical Marijuana Patients’ Gun Rights (Marijuana Moment)

• Consumers embrace concentrates as falling flower prices lead to cheaper extracts (Marijuana Business Daily)

• Legal Marijuana Access Tied To Lower Risk Of Lung Injuries From Contaminated Vapes, Study Indicates (Marijuana Moment)

• Creator Explains Patented Process To Extract Cannabinoids From Smoke (High Times)

• New Senate Bill Would Create Federal Marijuana Commission To Prepare For Legalization (Marijuana Moment)

• Colorado Regulators Issue Recall for Moldy Weed (High Times)

• Missouri Voters Back Marijuana Legalization Ballot Initiative In New Poll, But Support Is Tightening A Week Before Election Day (Marijuana Moment)

• Arkansas Marijuana Legalization Initiative In Jeopardy, New Poll Shows Days Before Election (Marijuana Moment)

• Only a Quarter of Virginia Drivers Said Driving on Pot is ‘Extremely Dangerous,’ Survey Shows (High Times)

Magic Mushrooms

• Compass Pathways Phase 2 Psilocybin Results far from Spectacular (Psychedelic Spotlight)

• North America’s First Take Home Psilocybin Trial Approved in Canada (High Times)

• Colorado Psychedelics Legalization Ballot Initiative Still Trails But Picks Up Support From Previously Undecided Voters, New Poll Finds (Marijuana Moment)

• Therapists who already incorporate psychedelics in their practice are mixed on Prop 122 (CPR News)

MDMA

• The Ecstasy of Agony (Truthdig)

Ayahuasca

• Using Ayahuasca and Psychedelic Plants to Treat Racial Trauma (Psychology Today)

San Pedro

• Nazca Human Sacrifice Victim Used Psychedelics Before Death (High Times)

Ketamine

• New study provides insight into the cognitive mechanisms underlying ketamine’s rapid antidepressant effects (PsyPost)

• Telehealth startups prescribing ketamine at home are stirring concern (STAT News)

• Is Ketamine the Drug of the Moment? (VICE)

Miscellaneous

• MAPS Prepares For Trial in Wrongful Death Lawsuit (Lucid News)

• The Harms of Psychedelics Need to Be Put Into Context (WIRED)

• US veterans with PTSD turn to psychedelic drugs overseas as VA frustration grows (Yahoo!)

• Why San Francisco Didn’t (Really) Decriminalize Psychedelics (DoubleBlind)

• Why Humans Have Always Been Fascinated by Snakes—From Ayahuasceros to Egyptians (DoubleBlind)

• How Does Race and Ethnicity Influence Psychedelic Mental Health Outcomes? (Psychedelic Spotlight)

11.11.22

Cannabis

• Maryland Becomes 20th State to Legalize Marijuana for Adult Use (NORML)

• Missouri Becomes 21st State to Legalize Marijuana for Adult Use (NORML)

• Ohio Voters Approve Marijuana Decriminalization Ballot Measures In Five Cities (Marijuana Moment)

• Wisconsin Voters Approve Marijuana Ballot Questions In Cities And Counties Across The State (Marijuana Moment)

• South Dakota Voters Reject Adult-Use Cannabis Second Time Around (High Times)

• Arkansas Marijuana Legalization Initiative Defeated By Voters (Marijuana Moment)

• North Dakota Rejects Bill To Legalize Adult-Use Cannabis (High Times)

• Texas Voters In Five Cities Approve Marijuana Decriminalization Ballot Initiatives (Marijuana Moment)

• Can cannabis help us win the war against antibiotic resistance? (Salon)

• Czech Republic Plans To Legalize Cannabis In Coordination With Germany (Forbes)

• Wisconsin Governor Pledges To Put Marijuana Legalization In Upcoming Budget After Voters Approve Reform On The Ballot (Marijuana Moment)

• Minnesota Senators Signal Plans To Advance Marijuana Legalization In 2023 With New Democratic Majority (Marijuana Moment)

• Arkansas Activists Plan Expanded 2024 Marijuana Ballot Initiative Following This Week’s Legalization Defeat (Marijuana Moment)

• Judge Tosses Out Lawsuit on Rule Barring Medical Cannabis Users From Buying Guns (High Times)

• FDA Finally Rejects Petition For Federal Exemption For Marijuana More Than A Decade After It Was Filed (Marijuana Moment)

• ‘Cannabis Use Disorder’ Pill Clinical Trial To Begin (High Times)

• Study Shows Smoking Weed Doesn’t Automatically Make You Cool (High Times)

• New Survey Details The Growing Importance Of Cannabis For Thanksgiving Celebrations (Forbes)

• Study Finds No Change in Cannabis Perception Among Youth in Adult-Use States (High Times)

LSD

• LSD induces both an “afterglow” for memory performance and a cognitive “hangover,” study finds (PsyPost)

• LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress (Benzinga)

Magic Mushrooms

• Several rural Oregon counties vote against therapeutic use of psilocybin (OPB)

• There’s Now a Shroom Dispensary in the US (DoubleBlind)

• The Heroic Dose: Navigating Powerful Mushroom Journeys (DoubleBlind)

MDMA

• MDMA Therapy is Almost Legal—But Who Will Have Access? (DoubleBlind)

• ‘Losing the Magic’: When MDMA Just Stops Working (VICE)

Ayahuasca

• Ayahuasca to blame for Aaron Rodgers' struggles, ESPN's Robert Griffin III suggests (Fox News)

• What Mainstream Churches Can Learn from an Ayahuasca Church (Lucid News)

5-MeO-DMT

• Feds Tell National Park Visitors To Stop Licking Psychedelic Toads (Marijuana Moment)

Novel Psychoactive Substances

• 5-HT2A Virtual Chemical Screen Produces New Candidate Antidepressants (Psychedelic Science Review)

Synthetic Cannabinoids

• Two hospitalised due to dangerous batch of synthetic cannabinoids (Stuff.co.nz)

Nitrous Oxide

• Home Office responds to call for retail sales ban on nitrous oxide (gasworld)

Ketamine

• Mom of 5 died after ketamine injection by a paramedic, family alleges in wrongful death suit (NBC)

Miscellaneous

• What a Trip: Coloradans Approve Landmark Psychedelics Measure (Westword)

• Wonderland Miami Exposes Growing Rift in Psychedelic Community (Psychedelic Spotlight)

• Psychedelic Training Provider Fluence Files Trademark for Common Phrase, Walks Back After Criticism (Psymposia)

• Psychedelic drug research held back by UK rules and attitudes, say scientists (The Guardian)

• Will the Psychedelic Revolution Be Medicalized? (Lucid News)

11.18.22

Cannabis

• Kentucky Governor Signs Executive Orders Allowing Medical Marijuana Possession From Other States And Regulating Delta-8 THC (Marijuana Moment)

• Congress Passes Landmark Cannabis Research Bill (High Times)

• Half of Dentists Say Patients Arrive to Checkups Stoned, Survey Finds (High Times)

• Nearly Seven In Ten Americans Back Marijuana Legalization, Including Majority Of Republicans, Latest Gallup Poll Finds (Marijuana Moment)

• Cows Given Hemp Feed To Produce Milk With THC (High Times)

• New York’s gray market cannabis crackdown begins in Brooklyn (Leafly)

• Study Finds Link Between Cannabis Use, Greater Physical Activity in HIV+ Patients (High Times)

• U.K. Researchers Launch Study Exploring Weed’s Effects on the Brain (High Times)

• Study Examines If CBD Buffers THC’s Effects (High Times)

Magic Mushrooms

• Nearly 70% of Oregon bans psilocybin, but clinics will still open next year (Leafly)

MDMA

• Second MAPS-Sponsored Phase 3 Trial of MDMA-Assisted Therapy for PTSD Completed (MAPS)

• Post-pandemic trends in the UK MDMA market and implications for harm reduction services (Volteface)

DMT

• Algernon Pharmaceuticals begins screening of first subject in phase 1 DMT human stroke study (Pharmabiz)

Ayahuasca

• Mind-altering South American brew causes adverse side effects, study says (UPI)

Novel Psychoactive Substances

• VIC Health Warns of 'Chemical Similar to PCP' Sold as Ketamine (VICE)

Nitrous Oxide

• Laughing Gas Is Being Banned In the Netherlands As Reports of Extreme Use Grow (VICE)

Ketamine

• Online Ketamine Clinics Face Tougher Times After Covid-Era Boom (Bloomberg)

Miscellaneous

• Bipartisan Lawmakers Form New Psychedelics Caucus In Congress (Marijuana Moment)

• Drug testing makes festivals safer, new research finds (Mixmag)

• Spiraling Down Wonderland’s Psychedelic Corporate Rabbit Hole (Lucid News)

• ‘How to Change Your Mind’ and the Destigmatisation of Psychedelics (Sam Woolfe)

• Elon Talks Psychedelics: Is he Helping or Hurting the Movement? (Microdose)

• Psychedelic drugs may reopen critical learning periods in the brain (New Scientist)

• Cory Booker And Rand Paul File Bill To Reschedule Psychedelic Breakthrough Therapies And Remove Research Barriers (Marijuana Moment)

• Philadose conference highlights psychedelic therapies in Pennsylvania (The Philadelphia Inquirer)

• Inside Detroit’s Trippy A-F “Psychedelic Healing Shack” (DoubleBlind)

• Would you let your teenager try psychedelics? (Drug Science)

11.25.22

Cannabis

• Krispy Kreme is paying to keep weed illegal (Leafly)

• Rhode Island To Begin Adult-Use Cannabis Sales on Dec. 1 (High Times)

• Oregon: Governor Announces Mass Pardons for Those with Low-Level Cannabis Convictions (NORML)

• Colombian Senators Approve Marijuana Legalization Bill (Marijuana Moment)

• North Carolina tribe begins first legal medical cannabis harvest in the state (Marijuana Business Daily)

• Irish Lawmaker Files Bill To Legalize Marijuana Possession For Adults, Draws Early Criticism From Top Government Official (Marijuana Moment)

• CBD did not help people who got too high, study finds (Leafly)

• New York Cannabis Farms Have $750 Million of Weed — and Nowhere to Sell It (Bloomberg)

• Just 10 Percent Of Americans Think Marijuana Should Be Totally Illegal, Pew Poll Finds (Marijuana Moment)

• Cops May Soon Be Able To Scan Your Eyeballs To See if You’re Driving Stoned (High Times)

• South Dakota Medical Marijuana Patients Won’t Be Denied Hunting Licenses, Official Says (Marijuana Moment)

• The Nose Knows! Study Shows Aroma Drives Cannabis Consumer Appeal (High Times)

• Federally Funded Study Shows Marijuana Legalization Is Not Associated With Increased Teen Use (Marijuana Moment)

• Southern Illinois University Examining the Use of Cannabis for Ovarian Cancer (High Times)

• No, marijuana is not more harmful than tobacco (Leafly)

• Idaho Activists Launch Signature Drive To Put Medical Marijuana Legalization On 2024 Ballot (Marijuana Moment)

LSD

• Beckley Foundation Announces LSD, Microdosing Research (High Times)

Magic Mushrooms

• Oregon's Newly Legal Magic Mushroom Industry Could Be Strangled by Restrictive Zoning Regulations (Reason)

Ayahuasca

• Study Finds Benefits Outweigh Risks of Ayahuasca Use (High Times)

5-MeO-DMT

• Psychedelic Brains In A Dish (Psychedelic Science Review)

Iboga

• I Tried Ibogaine, the Psychedelic Anti-Addiction Drug (VICE)

Synthetic Cannabinoids

• Utah moves to ban synthetic cannabinoids in medical marijuana products (Fox 13)

Ketamine

• Long-term Ketamine Treatment for Depression May Reduce Risk of Relapse (Lucid News)

• At-Home Ketamine Treatments Could Be a Game-Changer—or a Big Problem (Gizmodo)

• Amygdala connectivity predicts ketamine treatment response among patients with anxious depression (PsyPost)

• atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine Treatment (Psychedelic Alpha)

Miscellaneous

• There’s a Worldwide Spike in Arrests of Plant Medicine Practitioners (DoubleBlind)

• All Entheogens Welcome at this Post-Modern Oakland Church (Lucid News)

• How To Stop A Psychedelic Trip: The Promise of Ketanserin (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 5.7.21

Cannabis

• Mexican Lawmakers Fail To Legalize Marijuana Ahead Of Supreme Court Deadline (Marijuana Moment)

• Alabama Medical Marijuana Bill Heads To Governor’s Desk Following Legislature’s Approval (Marijuana Moment)

• Louisiana House Votes To Legalize Medical Marijuana Flower And Advances Bill To Prepare For Recreational Legalization (Marijuana Moment)

• Texas House Passes Marijuana Decriminalization Bill, Sending It To Senate (Marijuana Moment)

• Philadelphia: Mayor Signs Law Prohibiting Pre-Employment Drug Screening for Cannabis (NORML)

• Frequent Marijuana Consumers Are Actually More Physically Active Than Non-Users, Study Finds, Smashing Stereotypes (Marijuana Moment)

• Neat idea, Canna Bumps: Thanks for keeping marijuana illegal (Leafly)

• Switzerland Just Got One Step Closer to Federally Legalizing Weed (MERRY JANE)

• Cannabis Offers Immediate Nausea Relief, Study Shows (Forbes)

• French Lawmaker Displays Marijuana Joint In Parliament As New Report Calls For Legalization (Marijuana Moment)

• 58% of Americans Don't Know the Difference Between THC and CBD, Survey Says (MERRY JANE)

• Colorado Governor Signs Bill To Expand Medical Marijuana Access For Students In Schools (Marijuana Moment)

• Kansas: House Lawmakers Approve Medical Marijuana Bill (NORML)

• Minnesota Marijuana Legalization Bill Clears 11th House Committee On Path To The Floor (Marijuana Moment)

• Colorado: Legislature Approves Measure Eliminating Civil Penalties for Possessing Between One and Two Ounces of Cannabis (NORML)

• Kansas Lawmakers Approve Medical Marijuana Legalization Bill In Committee (Marijuana Moment)

• Wilmington, Delaware City Council Votes to Support Cannabis Legalization (NORML)

• Cannabis 'gravest threat' to mental health of young people (The Irish Times)

Magic Mushrooms

• MycoMeditations' Psilocybin-Assisted Wellness Retreat Urgently Addresses COVID-19's Impact on Mental Health (PR Newswire)

• Psychedelics and Veganism: Personal Change Catalysed by Psilocybin (Sam Woolfe)

• Psyched Wellness Signs Supply Agreement for Amanita Muscaria (Psilocybin Alpha)

• Psilocybin and the Will to Live (Psychedelic Science Review)

• Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol (Psilocybin Alpha)

MDMA

• A Psychedelic Drug Passes a Big Test for PTSD Treatment (The New York Times)

Mescaline

• A Century of Mescaline (Chacruna)

Synthetic Cannabinoids

• The Power of Synthetic Cannabinoids and Why Big Pharma Prefers Them (Cannabis Science and Technology)

Ketamine

• Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities (Psilocybin Alpha)

• Ketamine, esketamine effective for depression but have limitations (Healio)

• What’s in the ketamine bill that just passed the House Judiciary Committee in Colorado? (KDVR)

Miscellaneous

• 100 Most Influential People in Psychedelics (Psychedelic Invest)

• Texas House Approves Psychedelics Research Bill As Marijuana Reform Measures Also Advance (Marijuana Moment)

• Can a genetic test predict your response to psychedelic drugs? (New Atlas)

• What Happens When Big Pharma Starts Selling Mass-Market Hallucinogens (The Federalist)

• Now that New York Legalized Cannabis, Could Psychedelics Be Next? (DoubleBlind)

• The push to legalize psychedelics has ignored Indigenous communities (Mic)

• Psychedelics at a Crossroads: We Need Constructive Not Extractive Capital (Dr. Bronner's)

• Red Light Holland Receives Patent Pending Status For ‘Find Your Dose’ Customization of Microdosing Kits Based on Biometric and Movement Data (Psilocybin Alpha)

• Psychedelics are transforming the way we understand depression and its treatment (The Irish Times)

• Portland Advocates Push for Psychedelic Decriminalization (Truffle Report)

• Can Psychedelics Provide Relief for Autistic Individuals? (Psychedelics Today)

• Nova Mentis Launches Autism Clinical Study (Psilocybin Alpha)

• Why drugs should be not only decriminalised, but fully legalised (New Statesman)

• Ketanserin’s Contributions to Psychedelic Research (Psychedelic Science Review)

• MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics (Psilocybin Alpha)

• Navigating the Legal Landscape of Psychedelics (Sam Woolfe)

• Culture, entrepreneurial spirit makes Okanagan viable for psychedelic research (iNFOnews)

• Psychedelics and Ecological Consciousness (Reality Sandwich)

• DoubleBlind Editor-in-Chief Shelby Hartman on Covering the World of Psychedelics (Muse by Clio)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Month in Psychedelics - February 2021

Maybe it’s just me, but it was especially difficult to keep up with everything happening in the world of psychedelics this month. There are dozens of drug policy reforms and psychedelic research studies to keep up with, and making sure I’m covering each one and only reporting the most up-to-date news about them is extra tough when they change on a daily (and sometimes hourly) basis.

So I’ve tried my best to recap this month’s most important psychedelic news in this blog post. We’re going to cover a bunch of drug policy reforms, how patents are affecting the psychedelic industry, the latest events in psychedelic science, and much more.

Here is a slimmed-down video recap version that is available for those who prefer an easier-to-digest option:

There’s a lot to get through this month, so without further ado, let’s jump into the news:

Drug Policy

New Laws

Starting off this month’s recap with some good news and paving the way for the rest of the country, Oregon’s drug decriminalization bill went into effect. Now Oregonians will no longer face criminal charges for possessing small quantities of drugs and the state is prioritizing drug treatment over law enforcement.

Policy Reform Wins

Several other initiatives moved one step closer to becoming a reality—Cambridge, Massachusetts decriminalized psychedelics, New Jersey’s governor signed a whopping three reform bills (two separate bills that will legalize and decriminalize cannabis and a third bill that will reduce penalties for psilocybin possession), and the Democratic leaders in the U.S. Senate announced steps to federally legalize cannabis later this year.

In addition, both Virginia’s House and Senate voted to legalize cannabis, North Dakota’s House voted to legalize recreational marijuana, and Alabama’s Senate passed a bill to legalize medical marijuana.

Lawmakers on committees in five states voted in favor of six drug policy reform bills this month. Cannabis legalization efforts passed in Hawaii, Minnesota, New Mexico, and North Dakota, lawmakers in North Dakota also advanced a cannabis decriminalization bill, and a drug decrim bill in Washington made it out of the committee round. Just earlier this week the initiatives in Minnesota and New Mexico both passed their second rounds and will definitely be heading to each state’s House for further consideration.

Hanging on by a thread, Virginia’s lawmakers are facing a Saturday deadline to reconcile two different conflicting House and Senate cannabis legalization bills and at the moment things are looking tense. Hopefully they’ll get it all worked out.

Proposed and Submitted Bills

Several more bills have been either proposed or submitted: initiatives to decriminalize psychedelics in California and Vermont; bills that would permit access to psychedelics for seriously ill patients in Iowa and Missouri; legislation that would decriminalize all drugs in Kansas, Massachusetts, Vermont, and Washington; a new medical marijuana bill was introduced in Kansas; a bill to study psychedelics in Texas and a federal cannabis research bill; and California activists announced plans to work on legalizing magic mushrooms in 2022.

Prohibitionists Resist

The dying gasps of prohibitionists around the country can be heard in several states where there are efforts to overturn the will of voters that voted in favor of cannabis reforms last November. A judge in South Dakota ruled the state’s recreational marijuana measure unconstitutional and the governor delayed the launch of the state’s medical marijuana program until 2022, and the American Medical Association is attempting to overturn the medical marijuana vote in Mississippi and the Senate passed legislation to enact an alternate medical marijuana program from the one that voters approved in November.

In a future-proofing move, Idaho’s Senate passed a measure to block cannabis legalization even if voters approve it later on. For a bunch of teetotalers, that’s quite a paranoid move.

International News

On the international stage, an attempt to legalize the medical use of MDMA and psilocybin in Australia was rejected. But don’t worry—the fight’s not over yet because Mind Medicine Australia is challenging the decision.


And to round out this month’s drug policy update on a positive note, Norway is considering decriminalizing all drugs.

Psychedelic Industry

Psychedelic patents are a big area of concern in the psychedelic industry right now. In a controversial move, COMPASS Pathways submitted a patent application attempting to lay claim to pre-existing, common psychedelic therapy techniques including the use of soft furniture and holding hands.

Although the patent has not been granted, it just goes to show how psychedelic companies plan to use patents to gain an advantage over their competitors, with some even stooping as low as trying to patent things that have been a part of psychedelic culture long before these newfangled companies were around.

At this point, we can only hope that this patent application will be rejected. But in other cases, companies are already winning psychedelic patents.

A small biotech startup known as CaaMTech Inc. won a patent that will protect any new compositions and methods that are created by combining cannabinoids and psilocybin derivatives. So even though people have been combining cannabis and magic mushrooms for basically forever, now CaaMTech will own exclusive rights to any future pharmaceutical concoctions that come from combining the two drugs.

Psychedelic patents will continue to have a huge influence over how the industry evolves over the next few years. Hopefully they won’t completely ruin it.

Psychedelic Research

New Centers

The psychedelic research field is busier than ever before. Four new psychedelic research centers launched this month: Massachusetts General Hospital’s Center for Neuroscience of Psychedelics, COMPASS Pathways’ Drug Discovery Center, New York University’s Center for Psychedelic Medicine, and Aion Therapeutic’s new Aion International Center for Psychedelic Psychiatry in Jamaica.

Studies

There are several new studies to go over, including a preliminary clinical trial that found MDMA therapy to be more helpful at treating alcohol addiction than conventional treatment methods, a meta-analysis that showed MDMA therapy to be less effective for people who take antidepressants, a study that suggested that psychedelic researchers who admit to using the substances themselves are viewed as having less integrity than researchers who are psychedelically-naïve, a study that showed that people suffering from chronic suicidality were given quick relief by consuming regular oral doses of ketamine in a clinical setting, researchers found that the rapid antidepressant effects of ayahuasca are linked to changes in inflammatory biomarkers, and a neuroscience study indicated that LSD “frees” brain activity from anatomical constraints.

Although it hasn’t been published yet, one study that deserves mention is MindMed’s LSD neutralizer study, which is now underway and expected to be completed by the end of 2021.

In this study, MindMed is attempting to see if a 5-HT2A antagonist known as ketanserin is capable of safely and effectively stopping the effects of an LSD trip during LSD therapy sessions. This technique would be used if an active session got completely out of hand or simply became too uncomfortable for a client, and it’s come under a lot of scrutiny with many people arguing that it would be better for the full psychedelic trip to unfold than to halt it in its tracks.

While this study isn’t going to explore the efficacy of prematurely evacuating a psychedelic trip, at the very least we should know whether ketanserin is viable trip-killer within the year.

Announced Future Trials

Finishing up this month’s psychedelic research segment is a collection of clinical trials that will be conducted in the future. Algernon Pharmaceuticals will explore treating stroke survivors with DMT, PharmaTher wants to see if ketamine can help treat Parkinson’s disease, UC San Diego will explore using psilocybin to treat phantom limb pain for amputees, and Tryp Therapeutics will see if psilocybin can help people who suffer from over-eating disorders.

On a personal note, psilocybin helped me overcome some issues that I used to have with over-eating and so I’m interested to see how it fares in a clinical setting.

That’s a wrap on psychedelic research for this month. Even though it’s becoming increasingly tougher to keep up with it all, I’m more excited than ever before to see so much psychedelic science happening nowadays!

Denver Mushroom Dealer Avoids Prison

Next up is an update on a story from 2019 where the DEA raided a Denver man’s home because he was selling magic mushrooms in the city, which had just decriminalized psilocybin mushrooms a few months earlier. A federal judge decided against sending 29 year-old Kole Milner to prison, instead opting to sentence him to three years of probation and a fine of $5500.

This is actually a pretty encouraging turn of events, considering that just a few years ago the judge probably would’ve chosen the more punitive approach of imprisoning Miliner rather than slapping him with probation and a fine.

Just as a reminder, even though psilocybin mushrooms have been decriminalized in Denver, they haven’t been given the same sort of approval from the state of Colorado or the federal government, AND they haven’t been legalized, so while it’s ok at the municipal level to possess and use them, it’s not legal to sell them. Be smart and safe out there, y’all.

New Professional Psychedelic Associations

As psychedelics continue to become more mainstream, legal and medical professionals are banding together to create new psychedelic associations that will enable researchers and therapists to establish new standards of care and help attorneys understand the complexities of a constantly-changing drug policy landscape.

Some of the newest organizations include the Psychedelic Medicine Association; the American Society of Ketamine Physicians, Psychotherapists and Practitioners; the International Association of Psychedelic Nursing; Medicine Midwives, the Association of Entheogenic Practitioners; the Psychedelic Justice League; and the Psychedelic Bar Association.

If you’re a medical or legal professional then be sure to check out these new associations and get involved—your input could help shape the field of psychedelics for decades to come.

QAnon Shaman Turns Against Trump

This month there is a followup from January’s QAnon Shaman story, where self-described psychedelic guru Jake Angeli took part in the attempt to seize the U.S. Capitol and prevent the certification of President Joe Biden’s November election victory.

It turns out that there was at least one other psychedelic right-winger at the Capitol that day—William Watson, who was out on a $103,000 bond for LSD and cannabis trafficking charges, also took part in the insurrection.

But getting back to Angeli, although he was previously “horrendously smitten” with Trump, the QAnon Shaman eventually turned against the former President after not receiving a pardon that would have set him free. He even went as far as to offer to testify against Trump in his second impeachment trial.

It doesn’t look like Angeli got that chance though, as the trial came and went and I couldn’t find any confirmation that he was given the opportunity to air his testimony.

We may never get to hear impeachment testimony from the QAnon Shaman on how Trump duped him, Watson, and thousands of others into participating in the insurrection, but this whole saga is a great reminder that—contrary to popular belief—there are people of all political persuasions that use psychedelics, not just liberals.

Independent Investigation Finds Elijah McClain to Have Been a Victim of Police Violence

A young Black man named Elijah McClain died in August 2019 after he was stopped by Colorado police, put in a carotid hold, and injected with ketamine. The officers involved were never charged because prosecutors claimed to lack evidence that would prove the officers caused McClain’s death or that the force was unjustified.

However, an independent investigation found that the officers did not have a legal basis to stop, frisk, or restrain him. This means that McClain is no longer listed as a suspect but rather was a victim, which has brought a ton of relief to his mother, Sheneen McClain. Aurora, Colorado, which is the town where this event occurred, has announced that it will hire an independent police monitor after hearing results of the investigation. While this is only a small step toward justice, it’s still progress.

Meanwhile, officer’s involved with the suffocation death of a Black PCP user named Daniel Prude will not face charges, indicating that there is still a lot of police reform work to be done in this country.

Tim Leary’s Castalia Foundation Co-Opted by Conspiracy Theorists

In an interested turn of events, Timothy Leary’s Castalia Foundation has been co-opted by conspiracy theorists who have been sharing anti-mask content, praise for Donald Trump, and discussion about elite pedophile rings. It’s a crazy tale and definitely worth checking out.

Jamaica Is Facing a Marijuana Shortage

Cannabis farmers in Jamaica are struggling as the country is currently running low on ganja. An extended drought following heavy rains, an increase in local consumption, and less marijuana farmers have caused the worst shortage that the island has ever seen. It’s gotten so bad that even tourists have noticed, posting on travel websites about difficulties finding some grass to imbibe. Hopefully this year’s crop will fare better and Jamaica can get back to being one of the best countries for cannabis.

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.